United States 115th Congress Status: In Committee Bipartisan · 6 R · 3 D cosponsors

HR 3391 — Medical Marijuana Research Act of 2017

Last action — Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

Bill Text

How this bill changes current law

8 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill modifies the registration requirements for the manufacture and distribution of marijuana for research purposes under the Controlled Substances Act.

  • 21 U.S.C. 823(f)

    (f) The Attorney General → (f)(1) The Attorney General

    Renumbers the existing paragraph for clarity.

  • 21 U.S.C. 823(f)

    Registration applications → (2) Registration applications

    Renumbers and clarifies the registration application section.

  • 21 U.S.C. 823(f)

    schedule I → schedule I, except marijuana,

    Excludes marijuana from the standard registration framework for Schedule I substances.

  • 21 U.S.C. 823(f)

    Article 7 → (4) Article 7

    Clarifies the reference to Article 7.

  • 21 U.S.C. 823(f)

    (3)(A) The Attorney General shall register a practitioner to conduct research with marijuana if...

    Establishes specific criteria for registering practitioners researching marijuana.

  • 21 U.S.C. 823(f)

    If the Attorney General grants an application for registration under this paragraph, the applicant may amend or supplement the research protocol without reapplying if the applicant does not...

    Allows flexibility for researchers to amend protocols without needing to reapply for registration under certain conditions.

  • 21 U.S.C. 823(k)

    Beginning not later than the day that is 1 year after the date of enactment of the Medical Marijuana Research Act of 2017, the Attorney General shall register an applicant to manufacture marijuana...

    Institutes a new registration process for manufacturers of marijuana specifically for research purposes.

  • 21 U.S.C. 802(16)

    or `marijuana'

    Extends the definition of products associated with cannabis to include marijuana.

Action History

  1. Introduced in House

  2. Introduced in House

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Referred to the Subcommittee on Health.

  6. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 8 co-sponsors · 538 not signed on

Sponsors (1)

Co-sponsors (8)

Not signed on (538)

538 members have not signed on to this bill.

Show all 538 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 3391 do?
Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
Who sponsors HR 3391?
HR 3391 is sponsored by Blumenauer, Earl (Democratic), Griffith, H. Morgan (Republican), Lofgren, Zoe (Democratic), Norton, Eleanor Holmes (Democratic), Curbelo, Carlos (Republican), Amodei, Mark E. (Republican), Roe, David P. (Republican), Guthrie, Brett (Republican), and Harris, Andy (Republican).
What is the current status of HR 3391?
This bill died with 115th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 3391?
Track HR 3391 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 3391

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HR 3391

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →